• Written by Assay Depot
• Categorised Infographics

The US presidential election will soon come to a close today and many Americans will have casted their vote for the…

• Written by Maria Thompson
• Categorised Infographics, Outsourcing

Our latest infographic touches on a subject we care deeply about: the cost of drug discovery and the need for cost-effective…

• Written by Assay Depot
• Categorised Infographics

Animal testing is critical to advancing science and learning more about disease, but what animals are effective? It’s safe to say…

• Written by Assay Depot
• Categorised Infographics, Open Science

The 2011-2012 school year is over, so we decided the next infographic should take a look at how the sciences are…

• Written by Assay Depot
• Categorised Infographics

We’ve looked at what happens to a drug when a patent expires, but what happens to the patent owner? As patents have expired and many blockbuster drugs become generic, pharmaceutical companies have looked to new drugs and innovations to replace the lost income. Getting a drug through regulatory hurdles, such as clinical trials and safety testing, is difficult and millions of dollars can be lost from an unexpected failure. As many patents have expired and only a few drugs have replaced them in the past decade, pharmaceutical companies have looked to mergers and acquisitions for new products and drugs in an effort to buy innovation.